Squarepoint
NMTR

Squarepoint’s 9 Meters Biopharma NMTR Stock Holding History

Squarepoint’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-536
Closed -$3K – 3600
2022
Q2 		$3K Buy
+536
New +$5.05K ﹤0.01% 2807
2022
Q1 		– Sell
-630
Closed -$12K – 3748
2021
Q4 		$12K Sell
630
-29
-4% -$649 ﹤0.01% 3101
2021
Q3 		$17K Sell
659
-504
-43% -$11.9K ﹤0.01% 2826
2021
Q2 		$26K Sell
1,163
-6,123
-84% -$150K ﹤0.01% 3143
2021
Q1 		$170K Buy
+7,286
New +$224K ﹤0.01% 2762
2020
Q4 		– Sell
-6,070
Closed -$99K – 3369
2020
Q3 		$99K Buy
6,070
+5,367
+763% +$65.1K ﹤0.01% 2289
2020
Q2 		$8K Buy
+703
New +$7.93K ﹤0.01% 2169

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Squarepoint's NMTR Position: Q3 2022 in Review

Squarepoint sold out of 9 Meters Biopharma (NMTR) in Q3 2022, closing a stake of 536 shares — an estimated $3K sold.

Squarepoint first reported a position in NMTR in Q2 2020 and held it in 7 quarters. The position peaked at $170K in Q1 2021. 74 funds tracked by Wall St. Rank hold NMTR as of Q3 2022.

  • Squarepoint reported no remaining 9 Meters Biopharma position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 536 9 Meters Biopharma shares in Q3 2022, an estimated $3K.
  • Squarepoint first reported a position in 9 Meters Biopharma in Q2 2020 and held it in 7 quarters.
  • Squarepoint's 9 Meters Biopharma position peaked at $170K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.